Medtronic PLC Stock Underperforms Wednesday When Compared To Competitors

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Medtronic PLC (MDT) shares fell 1.23% to $92.60 on Wednesday, underperforming competitors like Johnson & Johnson and Abbott Laboratories during a broad market decline. This marks the second consecutive day of losses for Medtronic, which is now trading 12.91% below its 52-week high. Trading volume reached 9.9 million, exceeding the 50-day average.

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Medtronic PLC (MDT) slipped 1.23% to $92.60 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.45% to 7,551.81 and Dow Jones Industrial Average falling 1.21% to 51,461.90.

This was the stock's second consecutive day of losses.

Medtronic PLC closed 12.91% below its 52-week high of $106.33, which the company reached on November 26th.

The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.03% to $267.28, Danaher Corp. (DHR) fell 0.48% to $208.36, and Abbott Laboratories (ABT) rose 0.32% to $102.36.

Trading volume (9.9 M) eclipsed its 50-day average volume of 7.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 16, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-16-26 1637ET

Login to unlock611characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.